KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Non-Current Assets (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Non-Current Assets for 16 consecutive years, with $265.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 9.15% to $265.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 billion, a 10.25% decrease, with the full-year FY2024 number at $250.7 million, down 14.17% from a year prior.
  • Non-Current Assets was $265.5 million for Q3 2025 at Biolife Solutions, up from $261.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $428.9 million in Q3 2021 to a low of $46.6 million in Q4 2021.
  • A 5-year average of $278.6 million and a median of $292.1 million in 2023 define the central range for Non-Current Assets.
  • Biggest YoY gain for Non-Current Assets was 529.76% in 2021; the steepest drop was 61.2% in 2021.
  • Biolife Solutions' Non-Current Assets stood at $46.6 million in 2021, then rose by 3.55% to $48.3 million in 2022, then soared by 505.21% to $292.1 million in 2023, then fell by 14.17% to $250.7 million in 2024, then grew by 5.9% to $265.5 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Non-Current Assets are $265.5 million (Q3 2025), $261.8 million (Q2 2025), and $264.0 million (Q1 2025).